slides · global inventory
Plan Implementation
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 6,044
Current window 3,541-3,570
Pages 202
Rows per page 30
Slide function
3,541-3,570 of 6,044
12
The slide uses a two-column layout to separate milestones by drug candidate.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
25
The slide uses a structured table format to map clinical trial progress against specific disease indications.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
26
The diagram illustrates a dose escalation study design with three cohorts leading to the RP2D.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
36
Shows two parallel clinical tracks: monotherapy and combination with tislelizumab.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
07
The slide uses a Gantt-chart style layout to show the progression of various drug programs.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
08
Kymera | Investor Presentation Deck | 60 slidesKymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
37
The slide outlines a standard oncology dose-escalation study design (3+3 or similar) followed by expansion cohorts.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
44
The slide outlines a standard oncology clinical trial design (3+3 or similar dose escalation) followed by cohort expansion.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
57
The slide title mentions KT-333, but the content refers to KT-253 throughout; this is likely a typo in the source slide.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
07
The slide uses a before-after style transition (Heavily Pre-Treated to Earlier Lines) to frame the expansion strategy.Legend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
09
The slide uses color-coded bars to indicate geographic focus (Global, US, China) for each clinical program.Legend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Key Performance Indicators Overview1 hit
13
Legend Biotech | Results Presentation Deck | 16 slidesLegend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · RoadmapLoop · Why Now1 hit
06
Lightning eMotors | Results Presentation Deck | 25 slidesLightning eMotors | Results Presentation Deck | 25 slides · Lightning eMotors
Conference presentation Investor relations Beat · Satisfaction1 hit
08
The slide uses a three-column layout to represent the pillars, with supporting visuals for each (stacked bar chart, process flow, and map).Limbach Holdings | Investor Presentation Deck | 26 slides · Limbach
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
12
Uses a funnel-like diagram leading into a Venn-style circular cluster.Limbach Holdings | Investor Presentation Deck | 26 slides · Limbach
Pitch deck Investor relations 1 hit
13
The map uses color coding to distinguish between current branch locations/tuck-in opportunities and potential new target geographies.Limbach Holdings | Investor Presentation Deck | 26 slides · Limbach
Pitch deck Investor relations 1 hit
11
The slide uses a three-column layout to represent the pillars of their growth strategy.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations 1 hit
14
Uses a funnel-like diagram leading into a Venn-style hub-and-spoke model.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Business Model1 hit
15
The slide outlines two distinct M&A strategies: tuck-ins for existing markets and new geography expansion.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Business Model1 hit
04
The framework is named 'GEAR forward'.LKQ | Results Presentation Deck | 61 slides · LKQ
Conference presentation Investor relations 1 hit
06
The slide uses a linear process diagram to simplify the user experience.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
16
Mainz Biomed NV | Investor Presentation Deck | 25 slidesMainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Loop · Golden Circle1 hit
17
The slide uses a timeline format to show product development stages and commercial launch milestones.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Loop · Golden Circle1 hit
18
Slide 18 of a pitch deck.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Loop · Golden Circle1 hit
20
The timeline uses a DNA helix motif to represent the company's focus on molecular diagnostics.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Loop · Golden Circle1 hit
03
The chart uses a Gantt-style visualization to show progress across discovery, preclinical, and clinical phases.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
12
The slide uses a timeline-based process diagram to illustrate the clinical trial protocol.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
21
Uses a process-flow diagram to represent maturity levels (Proven, Under Evaluation, Future).Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
25
The slide uses a grid-based timeline format to track specific technical achievements and partnership milestones.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
05
The slide uses a Gantt-style chart to show the progress of various drug candidates through clinical development stages.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit